Stocks making the biggest moves after hours: AVAV, GEV, CBRL
Check out the companies making headlines in after-hours trading. AeroVironment — Shares of the defense technology provider slid more than 4% after its second-quarter earnings missed analyst expectations, coming in at 44 cents per share on an adjusted basis. That’s well below the 78 cents per share that analysts surveyed Continue Reading
Eli Lilly to build $6 billion Alabama manufacturing plant
Eli Lilly CEO David A. Ricks speaks at a press conference at Generation Park in Houston, Monday, Sept. 23, 2025. The company announced plans for a $6.5 billion biomanufacturing plant in north Houston. (Raquel Natalicchio/Houston Chronicle via Getty Images) Raquel Natalicchio | Houston Chronicle | Getty Images Eli Lilly on Continue Reading
We heard enough from Home Depot about next year and beyond to still believe in the stock
Jim Cramer has said Home Depot is the best way to play lower interest rates, and Tuesday’s trading in the stock shows us why. To Jim’s surprise, shares of the home improvement retailer ran as high as $356 each in the morning, despite management releasing disappointing guidance for the company’s Continue Reading
The Fed decision is expected to feature a rate cut and a lot more. Here’s what to expect
The Federal Reserve is poised to deliver its third straight interest rate cut Wednesday, while simultaneously firing a warning shot about what’s ahead. Following a period of remarkable indecision about which way central bank policymakers would lean, markets have settled on a quarter percentage point reduction. If that’s the case, Continue Reading
A biotech stock for investors scared to invest in the risky industry
Citigroup thinks investors should consider Ligand Pharmaceuticals for a more conservative bet on the biotech industry. The bank initiated the biotech stock at a buy rating and price target of $270, implying upside of 46% from Ligand’s Monday closing price of $184.67. Shares have soared nearly 79% this year. LGND Continue Reading
There’s no Dow or S&P 500 for cryptocurrencies yet. Bitwise is getting a step closer with new ETF
The new Bitcoin token is photographed on U.S. $100 bills. Sopa Images | Lightrocket | Getty Images A new exchange-traded fund from Bitwise that began trading Tuesday will give retail investors and financial advisors access to a broad range of cryptocurrencies in one shot, as opposed to the ETFs so Continue Reading
Pfizer strikes deal with YaoPharma for obesity pill
Pfizer CEO Albert Bourla talks during a press conference with European Commission President Ursula von der Leyen after a visit to oversee the production of the Pfizer-BioNtech COVID-19 vaccine at the factory of U.S. pharmaceutical company Pfizer in Puurs, Belgium April 23, 2021. John Thys | Reuters Pfizer on Tuesday Continue Reading
XOM, STAA, CVS, AZO, ARES
Check out the companies making the biggest moves midday: Campbell’s — The food company tumbled nearly 6% after it reported a 3% decrease in net sales from a year ago to $2.68 billion. Adjusted earnings also fell by 13% on a year-over-year basis to 77 cents per share. Both figures, Continue Reading
I may need to reevaluate Costco, plus a good sign for Linde
Every weekday, the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. 1. Stocks are higher ahead of Wednesday’s Federal Reserve interest rate decision. The U.S. central bank is expected to cut rates by 25 basis points, Continue Reading
FDA approves Merck drug for decimated cattle herds to stop screwworm
Cattle detained in the pens of the Chihuahua Regional Livestock Union , at the Jeronimo-Santa Teresa border crossing in Ciudad Juarez, Mexico on November 27, 2024, after the United States stopped imports of Mexican cattle due to the presence of screwworm. Anadolu | Anadolu | Getty Images U.S. cattle ranchers Continue Reading